Glenn Saldanha, managing director and CEO of Glenmark Pharmaceuticals, in an interview with CNBC-TV18's Udayan Mukherjee and Mitali Mukherjee, said that its business in India is growing at 23-24%, while its business in US is expected to grow 25% in FY12.
first published: May 11, 2011 10:46 am
A collection of the most-viewed Moneycontrol videos.
U.S.-Iran Conflict Will Have Huge Impact On Global Markets, Businesses, Supply Chain: Nalin Mehta
Rising Bharat Summit 2026 | “Satellite Can Go Where Others Can’t” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | “AI Creates More Opportunities” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | Piyush Goyal Answers the Big India–US Trade Deal Question
